Tom Brady Just Took a C‑Suite Job at a $2 Billion Company in the GLP‑1 Weight‑Loss Race
By Amaya Nichole
Published on March 27, 2026.
Former NFL quarterback Tom Brady has joined forces with Linda Yaccarino, CEO of eMed, to become the company's chief wellness officer. This comes as the market for GLP-1 weight-loss drugs is on the rise, with a projection of over $100 billion. The role requires collaboration between the company and the public.
Read Original Article